Felezonexor

N/A

Report date: 2025/02/19 16:44:00
NME

Base Information

Drug NameFelezonexor
Drug Alias NameSL-801CBS-9106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCanbas Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStemline Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A